Back

The v-wave shunt for left atrial decompression in patients with advanced chronic heart failure: fim safety and feasibility study

28 May 2018 (09:45 - 09:55)
Organised by:
Congress Presentation Part of: Late breaking trial III - Innovative and device therapy Treatment, Other HFA Premium Access Heart Failure 2018

About the speaker

Photo
Professor Stefan Anker

Charite University Hospital, Berlin (Germany)

11 More presentations in this session

Presentation thumbnail
Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients
Professor C. Linde (Stockholm, SE)
Slides Video
Presentation thumbnail
Discussion - CRT Survey II
Video
Presentation thumbnail
Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications
Professor M. Mehra (Boston, US)
Slides Video
Presentation thumbnail
Discussion - MOMENTUM 3
Video
Presentation thumbnail
Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry
Professor G. Hasenfuss (Goettingen, DE)
Slides Video

Access the full session

Session thumbnail
Late breaking trial III - Innovative and device therapy

The Event

Event poster

Heart Failure 2018

28 May 2018 09:45 CET
You may be interested in
thumbnail
Congress Presentation
Long-term transesophageal echocardiographic characterization of flow dynamics of the V-Wave Ventura Interatrial Shunt device in patients with advanced heart failure
22 May 2023
thumbnail
Congress Presentation
Safety and efficacy of pulmonary vein isolation during acute heart failure hospitalization
12 April 2026
thumbnail
Congress Presentation
Comparison of surgical treatment strategies in advanced heart failure patients
21 May 2023
thumbnail
Congress Presentation
LA reservoir strain predicts elevated left atrial pressure in patients with Veno-Arterial (VA) extracorporeal membrane oxygenator (ECMO) support for cardiogenic shock.
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources